Clinical Trial

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a non-randomized, multi-center, open-label clinical trial evaluating clinical feasibility treatments with the Profound Matrix system.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-12-04; most recent amendment 2025-08-18.
Status change: Recruiting → Active, Not Recruiting 2025-08-18
Trial Details
NCT Number NCT06157567
Lead Sponsor Candela Corporation
Conditions Skin Laxity, Wrinkle, Skin Condition
Enrollment 500 participants
Start Date 2022-05-24
Primary Completion 2027-05-24 (estimated)
Study Completion 2028-05-24 (estimated)
Updated on ClinicalTrials.gov 2025-08-22